We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+11.63%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$192M
AUM Growth
-$13.4M
Cap. Flow
-$34.2M
Cap. Flow %
-17.79%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
CELL
PhenomeX Inc. Common Stock
CELL
+$929K

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$11.4M
2
BLFS icon
BioLife Solutions
BLFS
+$11M
3
AZTA icon
Azenta
AZTA
+$7.68M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$5.08M
5
CTLT
CATALENT, INC.
CTLT
+$27.2K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.21B
$47.4M 24.69%
497,625
-79,143
-14% -$7.68M
CRL icon
2
Charles River Laboratories
CRL
$10.8B
$45.6M 23.73%
123,213
-34,028
-22% -$11.4M
CTLT
3
DELISTED
CATALENT, INC.
CTLT
$44.8M 23.34%
414,637
-254
-0.1% -$27.2K
BIO icon
4
Bio-Rad Laboratories Class A
BIO
$8.15B
$27.5M 14.32%
42,679
-8,344
-16% -$5.08M
CELL
5
DELISTED
PhenomeX Inc. Common Stock
CELL
$26.7M 13.92%
596,802
+20,035
+3% +$929K
BLFS icon
6
BioLife Solutions
BLFS
$1.42B
– –
-304,493
Closed -$11M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Tower House Partners held 6 positions worth $192M, down 6.5% from $205M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners withdrew a net $34.2M in Q2 2021, closing 1 position and reducing 4 holdings. Its most notable exit was BioLife Solutions, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Tower House Partners added an estimated $929K to PhenomeX Inc. Common Stock.

  • Tower House Partners added most to PhenomeX Inc. Common Stock in Q2 2021, an estimated $929K increase.
  • Tower House Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $11.4M.
  • Tower House Partners fully exited BioLife Solutions in Q2 2021, selling an estimated $11M.
  • Tower House Partners's ten largest holdings make up 100% of its $192M portfolio in Q2 2021.
  • Tower House Partners opened 0 new positions and closed 1 in Q2 2021.
  • Tower House Partners's portfolio value fell 6.5% quarter-over-quarter to $192M.

Based on Tower House Partners's 13F filing for Q2 2021, filed 17 Aug 2021.